SCHEMBL24944188

SCHEMBL24944188

CNc1nc(Nc2ccc(CN3CC4(COC4)C3)cc2)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 1/20 0.35
▸ TBK1 Q9UHD2 1/20 0.35
▸ EML4 Q9HC35 5/20 0.33
▸ ALK Q9UM73 5/20 0.33
▸ SYK P43405 3/20 0.33
▸ TLR8 Q9NR97 1/20 0.33
▸ TLR7 Q9NYK1 1/20 0.33
▸ CCNC P24863 2/20 0.33
▸ CDK8 P49336 2/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ PDGFRA P16234 3/20 0.32
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ CDK2 P24941 2/20 0.32
▸ AURKA O14965 1/20 0.32
▸ RET P07949 2/20 0.32
▸ ROS1 P08922 2/20 0.32
▸ FLT3 P36888 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ CCNA2 P20248 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30801879 1.00 IKBKE (0.35) IKBKETBK1EML4ALKSYK
Formic Acid SCHEMBL30206162 0.97 IKBKE (0.33) IKBKETBK1EML4ALKSYK
SCHEMBL24944496 0.92 LRRK2 (0.36) IKBKETBK1ALKTLR8TLR7
SCHEMBL30206172 0.92 LRRK2 (0.35) SYKTLR8TLR7CCNCCDK8
Formic Acid SCHEMBL30205591 0.90 LRRK2 (0.35) ALKTLR8TLR7CCNCCDK8
SCHEMBL24944183 0.89 SYK (0.44) EML4ALKSYKCCNCCDK8
SCHEMBL24944979 0.89 FLT3 (0.40) EML4ALKSYKLRRK2CDK2
SCHEMBL30205579 0.89 SYK (0.44) EML4ALKSYKCCNCCDK8
SCHEMBL30205675 0.89 FLT3 (0.40) EML4ALKSYKLRRK2CDK2
SCHEMBL24944172 0.88 TBK1 (0.39) IKBKETBK1EML4ALKSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback